Clinical trial
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified…
NCT00150371 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00150371 |
|---|---|
| Title | Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration |
| Official title | A Multicenter, 12 Week Treatment Single Step Titration Open-Label Study Assessing The % Of Patients Achieving Ldl-C Target With Atorvastatin Starting Doses Of 10mg, 20mg, 40mg and 80mg. |
| Acronym | CANACTFAST |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | atorvastatin |
| Enrollment | 1,100 |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 18, 2021 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: